Literature DB >> 17308562

Consumers' knowledge, perceptions, and responsiveness to direct-to-consumer advertising of prescription medicines.

Janet Hoek1, Ninya Maubach.   

Abstract

AIM: This research explored whether direct-to-consumer-advertising of prescription medicines (DTCA) increased disadvantaged consumers' knowledge of important health issues and encouraged those with lower health knowledge to consult their doctor (as has been argued by supporters of DTCA).
METHOD: A mail survey of 1042 New Zealanders was undertaken between October and December 2002 using a stratified random sample drawn from the electoral roll. After two reminders were sent, 632 completed questionnaires were returned (64% response rate). We examined the relationship between respondents' self-assessed knowledge of health-related issues, their perceived health status, and their response to DTCA (using self-efficacy theory to aid interpretation of the results).
RESULTS: Respondents with greater health knowledge found DTCA easier to understand and were more likely to have sought further information about an advertised medicine than those with less knowledge.
CONCLUSIONS: These results suggest DTCA may reinforce existing knowledge rather than educate or provide new knowledge. The results also cast doubt upon claims that DTCA enhances awareness of health issues among groups with lower health knowledge thus helping them overcome barriers to better health. Although changes to DTCA regulation could increase the information conveyed by this advertising, the advertising and pharmaceutical industries' failure to respond to well-documented concerns about DTCA raises serious questions about the power of policy refinements to control advertisers' conduct.

Mesh:

Year:  2007        PMID: 17308562

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  7 in total

1.  Time to ban direct-to-consumer prescription drug marketing.

Authors:  Kurt C Stange
Journal:  Ann Fam Med       Date:  2007 Mar-Apr       Impact factor: 5.166

2.  Industry funded patient information and the slippery slope to New Zealand.

Authors:  Les Toop; Dee Mangin
Journal:  BMJ       Date:  2007-10-06

3.  Seniors' perceptions of prescription drug advertisements: a pilot study of the potential impact on informed decision making.

Authors:  Jerry L Grenard; Visith Uy; José A Pagán; Dominick L Frosch
Journal:  Patient Educ Couns       Date:  2010-11-01

4.  Direct-to-Consumer Advertising of Prescription Drugs and the Patient-Prescriber Encounter: A Systematic Review.

Authors:  Jessica T DeFrank; Nancy D Berkman; Leila Kahwati; Katherine Cullen; Kathryn J Aikin; Helen W Sullivan
Journal:  Health Commun       Date:  2019-04-11

5.  Cancer-related direct-to-consumer advertising: awareness, perceptions, and reported impact among patients undergoing active cancer treatment.

Authors:  Gregory A Abel; Harold J Burstein; Nathanael D Hevelone; Jane C Weeks
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

6.  A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising.

Authors:  Dominick L Frosch; David Grande; Derjung M Tarn; Richard L Kravitz
Journal:  Am J Public Health       Date:  2010-01       Impact factor: 9.308

7.  Characteristics of medication advertisements found in US women's fashion magazines.

Authors:  Jennifer Mongiovi; Grace Clarke Hillyer; Corey H Basch; Danna Ethan; Rodney Hammond
Journal:  Health Promot Perspect       Date:  2016-12-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.